Please login to the form below

pharmaLevers GmbH

pharmaLevers GmbH is a Swiss based life science consulting firm in the area of Market Access (Pricing & Reimbursement, Health Economy, HTA and Policy).

This is a FREE listing




Below are full profiles from other companies in this area

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of patients is at the heart of our programmes; Sciterion are experts at rigorous insight generation and multi-stakeholder co-creation. Through a deep understanding of health behaviour, we align key stakeholder touchpoints to deliver intelligent, highly impactful and clinically relevant programmes. Our industry- leading standards of medical and scientific excellence, coupled with robust behavioural knowledge, advances clinical practice and optimises real world patient outcomes.

View profile

Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our collaborative cross-discipline approach enables us to create engaging, effective and measurable campaigns across channels to deliver distinctive solutions at every stage of a product’s lifecycle.

View profile

Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices. A vision to make a positive impact on the success of our clients, the economy and the wider society.

View profile

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

View profile

Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with our clients across Advisory, Healthcare Communications, Commercial, Patient Solutions and Medical Affairs to build tailored health solutions to deliver positive outcomes for patients.

View profile

Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and engaging messages to their target audience for over 25 years.

View profile

Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in a changing and challenging environment.

View profile

Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service healthcare marketing agencies. Our portfolio of market-leading media brands places Cogora at the heart of a highly engaged global community of 220,000 healthcare professionals. Cogora draws on the communities we’ve built to create compelling and practice changing educational programmes and marketing campaigns that resonate with their core audiences.

View profile

EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and adaptability critical for success. Our worldwide team of 190,000 industry-focused management consulting, compliance, business development and tax professionals — with deep sector knowledge and technical experience — can help you address these myriad changes and compete effectively in this dynamic environment. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities. Strength and depth in the Life Sciences sector EY is known for its deep power and Life Sciences sector knowledge, relationships with the industry’s key stakeholders, and strong global capabilities. Clients see us as the most globally connected organization among the Big Four. Whether you are already active in multiple geographies or are planning to expand your business to other countries, we can assemble a multinational team that combines deep industry knowledge, experience resolving the issues you are facing, and savvy local advice. Our Global Life Sciences Team is committed to delivering industry insight that creates value for you. It connects our Life Sciences professionals worldwide and serves as a hub for sharing industry-focused knowledge to help you succeed in a changing world. We make it our business to understand your business and to keep our advice relevant to your needs. We work with you as you transform your business, helping you anticipate the pitfalls and lock in the results on which your future depends. EY serves all of the Forbes Global 2000 top 10 life sciences companies and audits 26% of the global life sciences companies on the list. In addition, EY audits 30% of revenues of the global life sciences companies on the Forbes Global 2000 list. This broad and deep exposure means we understand the dynamics of the sector and the underlying drivers of the leading actors and our Global Life Sciences sector team, is dedicated to offering industry insight and coordinating a network of more than 7,500 Life Sciences professionals worldwide who are ready to develop practical approaches to solving your problems.

View profile

OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise in bringing the value of products to life for payer audiences. Through understanding the challenges involved in managing the entry and uptake of new drugs, devices and diagnostics, we develop robust strategic solutions allowing pharmaceutical companies to support budget holders and reimbursement stakeholders involved in managing the entry of new technologies into clinical practice at a Global, European and UK wide level.

View profile

Company Details

pharmaLevers GmbH

Telephone:+41 62 798 04 33

Contact

Address:
Mittlere Bühnenbergstrasse 16
Oftringen
4665
Switzerland

Latest content from PMHub

Confocal Microscope Market to Witness Notable Revenue Growth in North America Owing to Increasing Spending on R&D Initiatives in the Region
Confocal Microscope Market : Segmented by key players - Olympus Corporation, Leica Microsystem, ZEISS Group (Carl Zeiss Meditec AG), Nikon Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, Oxford Instruments plc., Confocal.nl, ISS.Inc, Thorlabs, Inc among others Future Market Insights
Confocal Microscope Market to Witness Notable Revenue Growth in North America Owing to Increasing Spending on R&D Initiatives in the Region
Confocal Microscope Market : Segmented by key players - Olympus Corporation, Leica Microsystem, ZEISS Group (Carl Zeiss Meditec AG), Nikon Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, Oxford Instruments plc., Confocal.nl, ISS.Inc, Thorlabs, Inc among others Future Market Insights
Western Blotting Processors Market Growth Challenged by High Costs, Low Innovation, and Unreliability of Automated Devices
Future Market Insights has announced the addition of the “Western Blotting Processors Market: Automated Dry Blotting System Expected to Remain Dominant Product Type During the Forecast Period: Global Industry Analysis (2013 - 2017) & Opportunity Assessment (2018 - 2028)" report to their offering Future Market Insights
High Cost Factor and Health Risks Arising from Surgical Procedures Restraining Revenues in the Hearing Implant Market
Future Market Insights has announced the addition of the “Hearing Implant Market: Cochlear Implant Expected to Remain Dominant Product Type During the Forecast Period: Global Industry Analysis (2013 - 2017) & Opportunity Assessment (2018 - 2028)" report to their offering Future Market Insights